Influenza vaccination in severely multiply handicapped persons/children

Vaccine

Volumn 24, Issue 19, 2006, Pages 4096-4101

  Otsuka, Taketo ^a   Fujinaka, Hidehiko ^a   Kamimura, Takanori ^a   Tanaka, Yasuki ^a   Hayakawa, Hiroshi ^a   Sato, Maki ^b   Syoubugawa, Yugo ^b   Saito, Reiko ^b   Suzuki, Hiroshi ^b   Tomizawa, Shuichi ^a  

^a Niigata National Hospital   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Antibody titer; Chemoprophylaxis; Influenza vaccine; Seroprotection rate; Severely multiply handicapped persons children

Indexed keywords

INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABLED PERSON; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; FEMALE; HIGH TEMPERATURE; HOSPITAL CARE; HUMAN; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE EDEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEX DIFFERENCE; SKIN REDNESS; VACCINATION REACTION; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; DISABLED PERSONS; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; MALE; MIDDLE AGED; VACCINES, INACTIVATED;

EID: 33646147344     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.044     Document Type: Article

References (27)

1. Bridges C.B., Thompson W.W., Meltzer M.I., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284 (2000) 1655-1663
2. Wilde J.A., McMillan J.A., Serwint J., et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 281 (1999) 908-913
3. Patriarca P.A., Weber J.A., Parker R.A., et al. Risk factors for outbreaks of influenza in nursing homes: a case-control study. Am J Epidemiol 124 (1986) 114-119
4. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
5. Morishima T., Togashi T., Yokota S., et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 35 (2002) 512-517
6. McCullers J.A., Facchini S., Chesney P.J., et al. Influenza B virus encephalitis. Clin Infect Dis 28 (1999) 898-900
7. CDC: Prevention and control of influenza, Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005;54(RR-8):1-40.
8. Hak E., Buskens E., van Essen G.A., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 165 (2005) 274-280
9. Dorrell L., Hassan I., Marshall S., et al. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers. Int J STD AIDS 8 (1997) 776-779
10. Nichol K.L., Baken L., and Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 130 (1999) 397-403
11. Boyle C.A., Decoufle P., and Holmgreen P. Contribution of developmental disabilities to childhood mortality in the United States: a multiple-cause-of-death analysis. Paediatr Perinat Epidemiol. 8 (1994) 411-422
12. Maudsley G., Hutton J.L., and Pharoah P.O. Cause of death in cerebral palsy: a descriptive study. Arch Dis Child. 81 (1999) 390-394
13. Reddihough D.S., Baikie G., and Walstab J.E. Cerebral palsy in Victoria, Australia: mortality and causes of death. J Paediatr Child Health 37 (2001) 183-186
14. World Health Organisation. International Classification of Functioning, Disability and Health (2002). http://www3.who.int/icf/icftemplate.cfm
15. Gross P.A., Russo C., Dran S., Teplitzky M., et al. Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 3 (1996) 361-362
16. Davies J.R., and Grilli E.A. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect 102 (1989) 325-333
17. Oxford J.S., Schild G.C., Potter C.W., et al. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) 82 (1979) 51-61
18. La Montagne J.R., Noble G.R., Quinnan G.V., et al. Summary of clinical trials of inactivated influenza vaccine. Rev Infect Dis 5 (1983) 723-736
19. Neuzil K.M., Dupont W.D., Wright P.F., et al. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985-1990: the pediatric experience. Pediatr Infect Dis J 20 (2001) 733-740
20. Zimmerman R.K., and Middleton D.B. Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2005. J Fam Pract 54 (2005) 27-36
21. Feery B.J., Cheyne I.M., Hampson A.W., et al. Antibody response to one and two doses of influenza virus subunit vaccine. Med J Aust. 1 186 (1976) 188-189
22. Levine M., Beattie B.L., and McLean D.M. Comparison of one- and two-dose regimens of influenza vaccine for elderly men. CMAJ. 137 (1987) 722-726
23. Gross P.A., Weksler M.E., Quinnan Jr. G.V., et al. Immunization of elderly people with two doses of influenza vaccine. J Clin Microbiol. 25 (1987) 1763-1765
24. Demicheli V., Jefferson T., Rivetti D., et al. Prevention and early treatment of influenza in healthy adults. Vaccine 18 (2000) 957-1030
25. Bowles S.K., Lee W., Simor A.E., et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc 50 (2002) 608-616
26. Shijubo N., Yamada G., Takahashi M., et al. Experience with oseltamivir in the control of nursing home influenza A outbreak. Intern Med. 41 (2002) 366-370
27. Parker R., Loewen N., and Skowronski D. Experience with oseltamivir in the control of a nursing home influenza B outbreak. Can Commun Dis Rep. 27 (2001) 37-40